Viewing Study NCT05755360


Ignite Creation Date: 2025-12-25 @ 2:13 AM
Ignite Modification Date: 2025-12-27 @ 12:39 PM
Study NCT ID: NCT05755360
Status: COMPLETED
Last Update Posted: 2025-10-02
First Post: 2023-02-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: DOORS: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes Who Change From Dipeptidyl Peptidase-4 Inhibitor (DPP4i) Treatment to Oral Semaglutide in Italy
Sponsor: Novo Nordisk A/S
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module